Demographics (3)
- age_onset - Disease onset age (phv00396373.v1.p1)
- sex - Gender of participant (phv00396375.v1.p1)
- SEX - Sex (phv00396369.v1.p1)
Disease Events (1)
- AFFECTION_STATUS - Case control status of the subject for erythromelalgia (phv00396364.v1.p1)
Geography (1)
- birthplace - Place of subject's birth (phv00396374.v1.p1)
Race and Ethnicity (1)
- race - Race of participant (phv00396376.v1.p1)
Other (18)
- ANALYTE_TYPE - Analyte type (phv00396382.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00396381.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00396363.v1.p1)
- FAMILY_ID - Family ID (phv00396365.v1.p1)
- FATHER - Father's Subject ID (phv00396368.v1.p1)
- genotype - NaV1.7 mutation (phv00396379.v1.p1)
- HISTOLOGICAL_TYPE - Histological type (phv00396384.v1.p1)
- IS_TUMOR - Tumor status (phv00396383.v1.p1)
- MOTHER - Mother's Subject ID (phv00396367.v1.p1)
- phenotype - Erythromelalgia phenotype (phv00396378.v1.p1)
- relationship - Familial relations (phv00396377.v1.p1)
- SAMPLE_ID - De-identified Sample ID (phv00396380.v1.p1)
- SAMPLE_ID - Sample ID (phv00396371.v1.p1)
- SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00396385.v1.p1)
- SUBJECT_ID - De-identified Subject ID (phv00396372.v1.p1)
- SUBJECT_ID - Unique Subject ID (phv00396366.v1.p1)
- SUBJECT_ID - Subject ID (phv00396362.v1.p1)
- SUBJECT_ID - Subject ID (phv00396370.v1.p1)